Etzer Darout
Stock Analyst at Barclays
(4.89)
# 279
Out of 4,352 analysts
464
Total ratings
56.3%
Success rate
25.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Etzer Darout
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JAZZ Jazz Pharmaceuticals | Reiterated: Buy | $234 → $253 | $236.49 | +6.98% | 5 | May 27, 2026 | |
| ABVX ABIVAX Société Anonyme | Maintained: Buy | $148 | $132.63 | +11.59% | 8 | May 26, 2026 | |
| ARVN Arvinas | Maintained: Buy | $20 | $8.98 | +122.72% | 34 | May 22, 2026 | |
| RLAY Relay Therapeutics | Maintained: Buy | $21 → $27 | $14.05 | +92.17% | 6 | May 20, 2026 | |
| CRVS Corvus Pharmaceuticals | Maintained: Buy | $28 | $12.41 | +125.62% | 6 | May 15, 2026 | |
| MNPR Monopar Therapeutics | Maintained: Buy | $125 | $65.04 | +92.19% | 6 | May 15, 2026 | |
| TRAX First Tracks Biotherapeutics | Maintained: Buy | $40 | $15.96 | +150.63% | 2 | May 15, 2026 | |
| ORKA Oruka Therapeutics | Rated: Buy | $160 | $58.53 | +173.36% | 7 | May 13, 2026 | |
| MGNX MacroGenics | Rated: Buy | $6 | $4.16 | +44.23% | 33 | May 13, 2026 | |
| ANAB AnaptysBio | Rated: Buy | $63 → $75 | $55.67 | +34.72% | 9 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $4.37 | +60.18% | 26 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $28 | $10.20 | +174.51% | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 | $27.16 | +194.55% | 7 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 → $48 | $31.43 | +52.72% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $3 | $3.40 | -11.76% | 5 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $11 | $4.10 | +168.29% | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $3.60 | +344.44% | 30 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $53 → $55 | $49.30 | +11.56% | 18 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $14 | $14.59 | -4.04% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $152 | $110.39 | +37.69% | 23 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $27 | $11.88 | +127.27% | 29 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $405 → $409 | $287.92 | +42.05% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 | $9.54 | +214.47% | 9 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 | $50.48 | -10.86% | 32 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $119 | $99.56 | +19.53% | 9 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $18 | $17.54 | +2.62% | 8 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $37 | $19.59 | +88.87% | 12 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $117 | $96.74 | +20.94% | 10 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $119 | $81.42 | +46.16% | 5 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $4.93 | n/a | 1 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 → $143 | $95.95 | n/a | 10 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $150.17 | n/a | 7 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.84 | n/a | 16 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.05 | n/a | 4 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $26.33 | n/a | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $17.76 | n/a | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.28 | n/a | 7 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.60 | n/a | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $63 | $0.829 | n/a | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 2,445 → kr 2,612 | $1,699.50 | n/a | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 → $37 | $101.50 | n/a | 2 | Sep 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $60 | $1.46 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $0.000001 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $25 | $5.99 | n/a | 2 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $4.65 | n/a | 2 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €22.30 → €25.73 | $4.29 | n/a | 2 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $162 | $301.98 | n/a | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $25.13 | n/a | 4 | Jul 14, 2020 |
Jazz Pharmaceuticals
May 27, 2026
Reiterated: Buy
Price Target: $234 → $253
Current: $236.49
Upside: +6.98%
ABIVAX Société Anonyme
May 26, 2026
Maintained: Buy
Price Target: $148
Current: $132.63
Upside: +11.59%
Arvinas
May 22, 2026
Maintained: Buy
Price Target: $20
Current: $8.98
Upside: +122.72%
Relay Therapeutics
May 20, 2026
Maintained: Buy
Price Target: $21 → $27
Current: $14.05
Upside: +92.17%
Corvus Pharmaceuticals
May 15, 2026
Maintained: Buy
Price Target: $28
Current: $12.41
Upside: +125.62%
Monopar Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $125
Current: $65.04
Upside: +92.19%
First Tracks Biotherapeutics
May 15, 2026
Maintained: Buy
Price Target: $40
Current: $15.96
Upside: +150.63%
Oruka Therapeutics
May 13, 2026
Rated: Buy
Price Target: $160
Current: $58.53
Upside: +173.36%
MacroGenics
May 13, 2026
Rated: Buy
Price Target: $6
Current: $4.16
Upside: +44.23%
AnaptysBio
May 13, 2026
Rated: Buy
Price Target: $63 → $75
Current: $55.67
Upside: +34.72%
May 13, 2026
Maintained: Buy
Price Target: $7
Current: $4.37
Upside: +60.18%
May 12, 2026
Rated: Buy
Price Target: $28
Current: $10.20
Upside: +174.51%
May 12, 2026
Rated: Buy
Price Target: $80
Current: $27.16
Upside: +194.55%
May 8, 2026
Rated: Buy
Price Target: $45 → $48
Current: $31.43
Upside: +52.72%
May 8, 2026
Rated: Sell
Price Target: $3
Current: $3.40
Upside: -11.76%
May 8, 2026
Rated: Buy
Price Target: $11
Current: $4.10
Upside: +168.29%
May 8, 2026
Rated: Buy
Price Target: $16
Current: $3.60
Upside: +344.44%
May 8, 2026
Rated: Buy
Price Target: $53 → $55
Current: $49.30
Upside: +11.56%
May 8, 2026
Rated: Sell
Price Target: $14
Current: $14.59
Upside: -4.04%
May 8, 2026
Rated: Buy
Price Target: $152
Current: $110.39
Upside: +37.69%
May 7, 2026
Rated: Buy
Price Target: $27
Current: $11.88
Upside: +127.27%
May 7, 2026
Rated: Buy
Price Target: $405 → $409
Current: $287.92
Upside: +42.05%
May 7, 2026
Rated: Buy
Price Target: $30
Current: $9.54
Upside: +214.47%
May 6, 2026
Maintained: Hold
Price Target: $45
Current: $50.48
Upside: -10.86%
May 6, 2026
Maintained: Buy
Price Target: $119
Current: $99.56
Upside: +19.53%
May 1, 2026
Rated: Hold
Price Target: $18
Current: $17.54
Upside: +2.62%
May 1, 2026
Maintained: Buy
Price Target: $35 → $37
Current: $19.59
Upside: +88.87%
Apr 29, 2026
Maintained: Buy
Price Target: $117
Current: $96.74
Upside: +20.94%
Dec 8, 2025
Maintained: Buy
Price Target: $70 → $119
Current: $81.42
Upside: +46.16%
Apr 4, 2025
Maintained: Buy
Price Target: $9
Current: $4.93
Upside: n/a
Mar 11, 2025
Maintained: Buy
Price Target: $130 → $143
Current: $95.95
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $150.17
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $2.84
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $11.05
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $26.33
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $17.76
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $4.28
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $1.60
Upside: n/a
Feb 27, 2025
Initiated Coverage: Buy
Price Target: $63
Current: $0.829
Upside: n/a
Aug 11, 2022
Maintained: Hold
Price Target: kr 2,445 → kr 2,612
Current: $1,699.50
Upside: n/a
Sep 13, 2021
Maintained: Buy
Price Target: $38 → $37
Current: $101.50
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $60
Current: $1.46
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Mar 17, 2021
Maintained: Buy
Price Target: $16 → $25
Current: $5.99
Upside: n/a
Mar 11, 2021
Reiterated: Buy
Price Target: $50 → $48
Current: $4.65
Upside: n/a
Mar 5, 2021
Maintained: Buy
Price Target: €22.30 → €25.73
Current: $4.29
Upside: n/a
Feb 22, 2021
Downgraded: Hold
Price Target: $162
Current: $301.98
Upside: n/a
Jul 14, 2020
Maintained: Buy
Price Target: $48
Current: $25.13
Upside: n/a